News

For decades, widely used pulse oximeters have underestimated the oxygen needs of darker-skinned patients. Will the FDA's new guidelines fix that?
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now the US Food and Drug Administration is proposing guidance to help make ...
A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more clinical data to show the devices accurately work across a range of skin tones.
It also not does address oximeters marketed as “health and wellness” devices, which typically are cheaper than FDA-cleared pulse oximeters and are sold over-the-counter.
By comparison, the last set of recommendations around pulse oximeters, which the FDA issued in a 2013 guidance, said that studies should include at least 10 people and include at least two people ...
In a 2007 draft guidance document, the FDA suggested that tests of new oximeters could “include a sufficient number of subjects with dark skin pigmentation, e.g., 30%.” ...
FDA's promised guidelines on pulse oximeters unlikely to end racial bias. Story by Guest Author • 5mo. Oakland, California — The patient was in his 60s, an African American man with emphysema.
The FDA held two advisory panel meetings — in 2022 and 2024 — to discuss the accuracy of pulse oximeters and ways to improve and evaluate their performance, and the agency issued a safety ...
State attorneys general and U.S. senators have pressed the FDA to take steps to eliminate pulse oximetry’s racial bias, which has caused delays in treatment and worse health outcomes, and more ...
Pulmonology > General Pulmonology FDA's Promised Guidance on Pulse Oximeters Unlikely to End Decades of Racial Bias — Devices three times as likely to miss dangerously low blood oxygen in Black ...
Its regulatory pathway for pulse oximeters clears them for sale as long as they show “substantial equivalence” to devices already on the market. In a 2007 draft guidance document, the FDA suggested ...